Corporate News 25-Jun-24
USFDA classifies inspection of Cipla's Patalganga unit as 'Voluntary Action Indicated'
Cipla announced that the United States Food and Drug Administration (USFDA) vide communication dated 25 June 2024 has classified the inspection of the company's manufacturing facility in Patalganga as Voluntary Action Indicated (VAI).
Previous News
Nifty scales above 26,050; IT shares advance
( Market Commentary - Mid-Session 26-Sep-24 10:37 )
Cipla’s UK arm inks pact to acquire 6.9124% stake in Cipla Jiangsu Pharmaceuticals
( Hot Pursuit - 26-Sep-24 10:27 )
Cipla to acquire JV partners' 6.91% in Cipla Jiangsu
( Corporate News - 25-Sep-24 17:38 )
Cipla Ltd up for third consecutive session
( Hot Pursuit - 11-Sep-24 13:06 )
Cipla announces board meeting date
( Corporate News - 04-Sep-24 17:50 )
Cipla vice-chairman M.K. Hamied resigns
( Hot Pursuit - 04-Sep-24 08:56 )
Board of Cipla approves change in directorate
( Corporate News - 03-Sep-24 18:49 )
Cipla Ltd spurts 1.99%, rises for fifth straight session
( Hot Pursuit - 30-Aug-24 13:00 )
Cipla Ltd up for five straight sessions
( Hot Pursuit - 12-Aug-24 13:00 )
Cipla Ltd gains for third straight session
( Hot Pursuit - 08-Aug-24 13:05 )
Cipla allots 6,815 equity shares under ESOS
( Corporate News - 02-Aug-24 18:26 )
Other Stories
Lippi Systems AGM scheduled
28-Sep-24 17:48
SPS Finquest to convene AGM
28-Sep-24 17:48
Emmforce Autotech to hold AGM
28-Sep-24 17:48
Purohit Construction to convene AGM
28-Sep-24 17:48
Rotographics (India) schedules AGM
28-Sep-24 17:47
Jupiter Infomedia to convene AGM
28-Sep-24 17:47
SRG Securities Finance AGM scheduled
28-Sep-24 17:47
Manoj Ceramic to conduct AGM
28-Sep-24 17:47
Sical Logistics to hold AGM
28-Sep-24 17:47
Galaxy Agrico Exports to conduct AGM
28-Sep-24 17:46
Back
Top
